VERVE THERAPEUTICS INC's ticker is VERV and the CUSIP is 92539P101. A total of 137 filers reported holding VERVE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.34 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $39,179,455 | -11.5% | 2,954,710 | +25.2% | 4.34% | +12.1% |
| Q2 2023 | $44,260,706 | +44.7% | 2,360,571 | +11.3% | 3.87% | +53.6% |
| Q1 2023 | $30,578,634 | -31.0% | 2,120,571 | -7.4% | 2.52% | -26.6% |
| Q4 2022 | $44,322,549 | -59.4% | 2,290,571 | -27.9% | 3.43% | -52.1% |
| Q3 2022 | $109,170,000 | +127.7% | 3,178,167 | +1.3% | 7.17% | +76.9% |
| Q2 2022 | $47,951,000 | -33.0% | 3,138,167 | 0.0% | 4.05% | +26.3% |
| Q1 2022 | $71,613,000 | -38.1% | 3,138,167 | 0.0% | 3.21% | -1.5% |
| Q4 2021 | $115,704,000 | -19.0% | 3,138,167 | +3.3% | 3.26% | -8.2% |
| Q3 2021 | $142,794,000 | -22.0% | 3,038,167 | 0.0% | 3.55% | -23.5% |
| Q2 2021 | $183,050,000 | – | 3,038,167 | – | 4.65% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alphabet Inc. | 10,974,011 | $167,683,000 | 9.10% |
| ARCH Venture Management, LLC | 2,508,809 | $38,335,000 | 4.67% |
| Casdin Capital, LLC | 3,138,167 | $47,951,000 | 4.05% |
| M28 Capital Management LP | 178,500 | $2,727,000 | 3.06% |
| Redmile Group, LLC | 1,833,547 | $28,017,000 | 1.07% |
| Cormorant Asset Management, LP | 700,710 | $10,707,000 | 0.81% |
| Novo Holdings A/S | 927,100 | $14,166,000 | 0.70% |
| Pinz Capital Management, LP | 51,800 | $792,000 | 0.54% |
| PFM Health Sciences, LP | 845,186 | $12,914,000 | 0.49% |
| Artal Group S.A. | 400,000 | $6,112,000 | 0.33% |